🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1 study with 2 parallel groups of healthy participants. Par...
Status
Active Not Recruiting
Location
Clinical Pharmacology of Miami- Site Number : 8400001
Start Date
2026-06-11
Trial ID
NCT07646548
Treatments Being Tested
This observational research study is to better understand patients with eos...
Status
Active Not Recruiting
Location
Phoenix Childrens Hospital
Start Date
2024-11-22
Trial ID
NCT06693531
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab in children 6 to ...
Status
Completed
Location
Investigational Site Number 840031
Start Date
2017-04-21
Trial ID
NCT02948959
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab, compared with pl...
Status
Completed
Location
Investigational Site Number 840022
Start Date
2015-10-15
Trial ID
NCT02528214
The objective of the program is to provide patients with Bullous Pemphigoid...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT05906706
Treatments Being Tested
This study is researching an experimental drug called dupilumab (called "st...
Status
Recruiting
Location
Phoenix Childrens Hospital
Start Date
2025-11-10
Trial ID
NCT07112378
Treatments Being Tested
This study is researching a drug called dupilumab. The study is focused on ...
Status
Active Not Recruiting
Location
Kern Research, Inc
Start Date
2024-08-26
Trial ID
NCT06572228
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab (SAR231893 / REGN...
Status
Completed
Location
Investigational Site Number 840047
Start Date
2015-04-27
Trial ID
NCT02414854
The main objective of the trial is to evaluate the efficacy of 2 dose regim...
Status
Completed
Location
Site 1
Start Date
2016-01-31
Trial ID
NCT02755649
Treatments Being Tested
The main objective of the trial is to demonstrate the efficacy of dupilumab...
Status
Completed
Location
Regeneron Research Site
Start Date
2017-11-17
Trial ID
NCT03345914